MCS
The Marcus Corporation
MCS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
TMUS
T-Mobile US, Inc.
TMUS has a slight edge over MCS overall, supported by stronger valuation and stronger modeled upside.
MCS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
MCS's revenue, profitability, cash flow and balance sheet are all currently healthy.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
MCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 31x | $27.22 | — |
| Cheap | 32x | $24.94 | -8.4% |
| Current | 34x | $27.22 | — |
| Fair | 42x | $33.12 | +22% |
| Expensive | 429x | $339 | +1145% |
Historical ranges are pointers, not guarantees.
MCS's PE is in its cheap range at 34x. If earnings grow as analysts expect, today's price would be 31x next year's earnings.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS has the edge over MCS in the historical PE scenario, which offers more potential upside but is not a forecast.
MCS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect MCS's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
TMUS has the edge over MCS on the outlook, with more favorable revenue expectations.
MCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.87 | +10% |
| Q3 2026 | $0.79 | +216% |
| Q2 2026 | $0.71 | +54% |
| Q1 2026 | $0.44 | +$0.84 |
| Q4 2025 | $0.41 | +$0.65 |
| Q3 2025 | $0.25 | +$0.49 |
| Q2 2025 | $0.46 | +$1.13 |
| Q1 2025 | -$0.40 | -238% |
| Q4 2024 | -$0.24 | -167% |
MCS has the edge over TMUS on earnings, with more consistent year-over-year improvement.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS earned $10.37 per share over the past year, about the same as the year before.
MCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $237.8M | +13% |
| Q2 2026 | $231.7M | +12% |
| Q1 2026 | $154.4M | +3.8% |
| Q4 2025 | $193.5M | +2.8% |
| Q3 2025 | $210.2M | -9.7% |
| Q2 2025 | $206M | +17% |
| Q1 2025 | $148.8M | +7.4% |
| Q4 2024 | $188.3M | +17% |
MCS's revenue has grown year over year for four quarters in a row: $238M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +1.9 points |
| Q2 2026 | 12% | +5.4 points |
| Q1 2026 | -12% | +1.3 points |
| Q4 2025 | 0.9% | +2.1 points |
| Q3 2025 | 11% | -3.3 points |
| Q2 2025 | 6.3% | +5 points |
| Q1 2025 | -14% | -1.7 points |
| Q4 2024 | -1.2% | -1.9 points |
MCS's operating margin was 13% last quarter, up 1.9 points from the same quarter a year ago, near the top of its range since 2019.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS's revenue has grown year over year for 10 quarters in a row: $23.6B last quarter, up 7.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over MCS on profitability, with a higher operating margin.
MCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.4M | +56% |
| Q2 2026 | $44M | +198% |
| Q1 2026 | -$21.9M | +$36.5M |
| Q4 2025 | $26.4M | -2.7% |
| Q3 2025 | $18.2M | +51% |
| Q2 2025 | $14.7M | -8.7% |
| Q1 2025 | -$58.3M | -$27.8M |
| Q4 2024 | $27.1M | +29% |
MCS generated $77M in free cash flow over the past year, more than ten times what it generated the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over MCS on cash flow, with more consistent year-over-year improvement.
MCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +455K shares |
| 1 year | +1.1% | +329K shares |
| 3 years | -23% | -9.5M shares |
| 5 years | +0.3% | +100K shares |
| Available history | +1.1% | +352K shares |
MCS has 32M diluted shares, up 1.1% from a year ago.
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over MCS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
MCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 1.4x | Healthy |
MCS's net debt is less than a year of its operating earnings (EBITDA), down from 1.9 years a year ago.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS has the edge over MCS on leverage, with a lower net debt burden relative to earnings.
MCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.6 | Neutral |
| Stochastic | 21.4 | Neutral |
MCS's weekly RSI is 59 (neutral) and its Stochastic is 21 (neutral).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
MCS PE vs Communication Services Sector
| Metric | MCS | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 16x | 109% above |
| PE % | 23 | 26 | 3 pts below |
MCS is trading at 34x earnings, a 109% premium to the Communication Services sector's median of 16x.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS has the edge over MCS on valuation relative to its sector.
MCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 0.4% below |
| 20 week MA | $27.1 | 0.6% above |
| 50 week MA | $21.3 | 28% above |
| 100 week MA | $19.2 | 42% above |
| 200 week MA | $17.1 | 59% above |
MCS has the edge over TMUS on trend strength, trading above more of its moving averages.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9.4% below its 200-week average.
MCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.9 | $12.5 | -61% |
| 2021 | $12.5 | $17.9 | +44% |
| 2022 | $17.9 | $13.9 | -22% |
| 2023 | $13.9 | $14.6 | +4.8% |
| 2024 | $14.6 | $21.4 | +47% |
| 2025 | $21.4 | $15.4 | -28% |
| 2026 YTD | $15.4 | $27.2 | +77% |
MCS has the edge over TMUS on returns for 2026, with the stronger performance.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has finished higher in four of the last six years. It's down 15% so far in 2026.